Wafaa R Mohamed

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Benign Prostatic Hyperplasia

Signaling Pathway

Epithelial Mesenchymal Transition

Lower Urinary Tract Symptoms

Top Venues

Inflammopharmacology

Journal of biochemical and molecular toxicology

Drug and chemical toxicology

Journal of food biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Sara I Shafiey, Kawkab A Ahmed, Ali A Abo-Saif, Amira M Abo-Youssef, Wafaa R Mohamed
Galantamine mitigates testicular injury and disturbed spermatogenesis in adjuvant arthritic rats via modulating apoptosis, inflammatory signals, and IL-6/JAK/STAT3/SOCS3 signaling. Inflammopharmacology (2023)
Maha M Abdel-Fattah, Mohammed E Abo-El Fetoh, Hassan Afify, Laila A A Ramadan, Wafaa R Mohamed
Probenecid ameliorates testosterone-induced benign prostatic hyperplasia: Implications of PGE-2 on ADAM-17/EGFR/ERK1/2 signaling cascade. Journal of biochemical and molecular toxicology (2023)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mohammed E Abo-El Fetoh, Maha M Abdel-Fattah, Wafaa R Mohamed, Laila A A Ramadan, Hassan Afify
Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia. Inflammopharmacology 31 (1) (2022)
Mayada G Elhennawy, Eglal A Abdelaleem, Amal A Zaki, Wafaa R Mohamed
Cinnamaldehyde and hesperetin attenuate TNBS-induced ulcerative colitis in rats through modulation of the JAk2/STAT3/SOCS3 pathway. Journal of biochemical and molecular toxicology 35 (5) (2021)
Emad H M Hassanein, Wafaa R Mohamed, Marwa M Khalaf, Abdel-Gawad S Shalkami, Ahmed M Sayed, Ramadan A M Hemeida
Diallyl disulfide ameliorates methotrexate-induced nephropathy in rats: Molecular studies and network pharmacology analysis. Journal of food biochemistry 45 (6) (2021)
Yasmin T Mohamed, Ibrahim A Naguib, Ali A Abo-Saif, Wafaa R Mohamed
Protective effects of perindopril against indomethacin-induced gastric mucosal damage through modulation of DDAH-1/ADMA and ACE-2/ANG-(1-7) signaling pathways. Drug and chemical toxicology (2021)